Yes, LEEP results can show cancer. The tissue removed during a LEEP procedure is sent to a pathology lab, where it’s examined under a microscope. That examination can reveal anything from mild precancerous changes to invasive cervical cancer. In one study of 158 women who underwent LEEP, 8.2% were diagnosed with invasive cervical cancer on their final pathology report.
What LEEP Results Actually Tell You
A LEEP (loop electrosurgical excision procedure) removes a cone-shaped piece of tissue from the cervix using a thin, heated wire loop. Unlike a small punch biopsy taken during colposcopy, the LEEP specimen gives pathologists a much larger, more complete sample to examine. This is one of its biggest advantages: it can catch abnormalities that smaller biopsies miss entirely.
Your pathology report will classify the tissue into one of several categories. The most common findings are graded by severity:
- CIN 1: Mild precancerous changes, often caused by HPV and likely to resolve on their own.
- CIN 2: Moderate precancerous changes that are less likely to go away without treatment.
- CIN 3 or carcinoma in situ: Severe precancerous changes. The abnormal cells haven’t spread beyond the surface layer of the cervix, but they need treatment.
- Adenocarcinoma in situ (AIS): Precancerous changes in the glandular cells of the cervix, which line the cervical canal.
- Invasive squamous cell carcinoma or invasive adenocarcinoma: Cancer that has grown beyond the surface layer into deeper cervical tissue.
The report will also describe the margins of the tissue sample, meaning whether abnormal cells were found at the edges of the removed tissue. This detail matters for determining whether the LEEP likely removed the entire lesion or whether some abnormal tissue may remain.
How Often LEEP Finds Cancer
Most women who undergo LEEP will not receive a cancer diagnosis. The procedure is typically done to treat or further evaluate high-grade precancerous changes (CIN 2 or CIN 3) that were found on an earlier biopsy. But a small percentage of cases do get upgraded to invasive cancer once the full tissue specimen is analyzed.
In a study of women with abnormal Pap smear results who underwent LEEP, 61.4% had CIN 3 or worse on their final pathology. Among those CIN 3-or-worse cases, 13.4% turned out to have invasive cervical cancer. That translated to 13 out of 158 women total. These were cancers that couldn’t be fully appreciated from the earlier, smaller biopsies alone.
LEEP Catches Cancers That Biopsies Miss
One of the most important roles of LEEP is detecting what doctors call “occult” cervical cancer, meaning cancer that is present but hidden from the standard diagnostic steps that came before. Colposcopy-directed biopsies and endocervical curettage (a scraping of the cervical canal) are the usual first-line tools, but they sample only small areas and can miss lesions, particularly when the cervix appears smooth or when abnormal cells are located higher in the canal where they’re harder to reach.
A large multicenter study in China examined 1,299 women at high risk for early-stage cervical cancer who had already undergone colposcopy-directed biopsy and endocervical curettage. Twenty of those women were ultimately diagnosed with early-stage invasive cancer (stages IA1 through IB1) only after conization, which includes LEEP. Their cancers had been completely missed by the earlier biopsies. That’s a 52.6% miss rate among the cancers in the study, and it accounted for 1.6% of all patients who underwent the standard biopsy workup. The researchers concluded that conization is necessary for detecting these hidden cancers, especially when the cervix looks normal during colposcopy.
Glandular Lesions Carry Higher Stakes
Not all LEEP findings carry the same implications. When the pathology report shows a squamous lesion like CIN 2 or CIN 3, the LEEP itself is often sufficient treatment. The abnormal tissue has been removed, and follow-up monitoring can begin.
Glandular lesions are a different story. Adenocarcinoma in situ (AIS) develops in the cells that line the cervical canal, and these lesions tend to grow in a patchy, “skip” pattern that makes them harder to fully remove. The standard treatment for AIS is hysterectomy, which is significantly more aggressive than what’s typically recommended for squamous precancers. When post-procedure sampling of the cervical canal comes back positive for residual AIS, the risk of finding leftover glandular disease is extremely high. In one analysis, 78% of women with a positive post-procedure canal sample had residual AIS, and 17% had invasive adenocarcinoma.
If your LEEP results show AIS, expect a more in-depth conversation with your doctor about next steps. For women who still want to have children, close surveillance with repeat procedures may be an option, though hysterectomy is generally recommended once childbearing is complete.
What Margin Status Means for You
Your pathology report will note whether the margins are “negative” (clear) or “positive” (involved). Negative margins mean the edges of the removed tissue appear free of abnormal cells, suggesting the entire lesion was removed. Positive margins mean abnormal cells extend to the edge of the specimen, which raises the possibility that some precancerous or cancerous tissue was left behind.
Positive margins don’t automatically mean you have cancer or that your treatment failed. Current guidelines from the American Society for Colposcopy and Cervical Pathology (ASCCP) offer several management options: a repeat LEEP to remove more tissue, hysterectomy, or follow-up in six months with HPV testing or colposcopy with endocervical curettage. The right path depends on whether the margin involvement is CIN 2, CIN 3, or something more serious, and on your age, fertility goals, and overall clinical picture.
What Happens If Cancer Is Found
If your LEEP pathology comes back showing invasive cancer, the findings will be used to help determine the stage. Very early-stage cancers (particularly stage IA1, where the invasion is less than 3 millimeters deep) may have been fully treated by the LEEP itself, and in some cases no further surgery is needed beyond close follow-up.
For cancers that have invaded more deeply, additional treatment is required. This typically involves imaging to assess how far the cancer has spread, followed by surgery (often a radical hysterectomy) or radiation-based treatment. You’ll be referred to a gynecologic oncologist, a surgeon who specializes in cancers of the reproductive system, to guide the next steps. The key point is that cancers caught at this stage, through a LEEP, tend to be early-stage and highly treatable. Detection at this point is far better than detection later.
LEEP vs. Cold Knife Cone Biopsy
LEEP is sometimes compared to a cold knife cone biopsy (CKC), which removes a similar cone of tissue using a scalpel rather than an electrical loop. For years, cold knife conization was considered the better option for glandular lesions like AIS, largely because earlier studies showed LEEP had a higher rate of positive margins. More recent research and systematic reviews have found the two procedures are equally effective at achieving clear margins, detecting invasive cancer, and preventing recurrence. Current ASCCP guidelines don’t recommend one over the other for most situations.
Your doctor may still prefer a cold knife cone in specific scenarios, such as when a larger or deeper tissue sample is needed, or when the electrical current from LEEP could damage the edges of the specimen and make it harder for the pathologist to evaluate margins accurately. But for the vast majority of women, LEEP provides the same diagnostic information with a shorter procedure time and faster recovery.